Benzinga | Jan 27, 2022 04:33AM EST

SVB Leerink Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $130

SVB Leerink analyst Danielle Antalffy maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $132 to $130.